Trademark Overview
On Wednesday, December 1, 2021, a trademark application was filed for CELLVERA with the United States Patent and Trademark Office. The USPTO has given the CELLVERA trademark a serial number of 97150676. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 20, 2023. This trademark is owned by AiPharma Global Holdings LLC. The CELLVERA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Drugs and pharmaceuticals both solids and liquid; Pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores
Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals